Source and role of intestinally derived lysophosphatidic acid in dyslipidemia and atherosclerosis

Source and role of intestinally derived lysophosphatidic acid in dyslipidemia and atherosclerosis

We previously reported that i) a Western diet increased levels of unsaturated lysophosphatidic acid (LPA) in small intestine and plasma of LDL receptor null (LDLR−/−) mice, and ii) supplementing standard mouse chow with unsaturated (but not saturated) LPA produced dyslipidemia and inflammation. Here...

Full description

Bibliographic Details
Main Authors:	Mohamad Navab, Arnab Chattopadhyay, Greg Hough, David Meriwether, Spencer I. Fogelman, Alan C. Wagner, Victor Grijalva, Feng Su, G.M. Anantharamaiah, Lin H. Hwang, Kym F. Faull, Srinivasa T. Reddy, Alan M. Fogelman
Format:	Article
Language:	English
Published:	Elsevier 2015-04-01
Series:	Journal of Lipid Research
Subjects:	lysophosphatidylcholine 6F peptide apolipoprotein A-I mimetic peptides genetically engineered tomato plants
Online Access:	http://www.sciencedirect.com/science/article/pii/S0022227520355681

Similar Items

Tg6F ameliorates the increase in oxidized phospholipids in the jejunum of mice fed unsaturated LysoPC or WD[S]
by: Arnab Chattopadhyay, et al.
Published: (2016-05-01)

Transgenic 6F tomatoes act on the small intestine to prevent systemic inflammation and dyslipidemia caused by Western diet and intestinally derived lysophosphatidic acid[S]
by: Mohamad Navab, et al.
Published: (2013-12-01)

Intestine may be a major site of action for the apoA-I mimetic peptide 4F whether administered subcutaneously or orally[S]
by: Mohamad Navab, et al.
Published: (2011-06-01)

Transgenic tomatoes expressing the 6F peptide and ezetimibe prevent diet-induced increases of IFN-β and cholesterol 25-hydroxylase in jejunum
by: Pallavi Mukherjee, et al.
Published: (2017-08-01)

D-4F-mediated reduction in metabolites of arachidonic and linoleic acids in the small intestine is associated with decreased inflammation in low-density lipoprotein receptor-null mice
by: Mohamad Navab, et al.
Published: (2012-03-01)

A novel method for oral delivery of apolipoprotein mimetic peptides synthesized from all L-amino acids
by: Mohamad Navab, et al.
Published: (2009-08-01)

Enhancement by LDL of transfer of L-4F and oxidized lipids to HDL in C57BL/6J mice and human plasma
by: David Meriwether, et al.
Published: (2011-10-01)

Lipoprotein inflammatory properties and serum amyloid A levels but not cholesterol levels predict lesion area in cholesterol-fed rabbits
by: Brian J. Van Lenten, et al.
Published: (2007-11-01)

A novel approach to oral apoA-I mimetic therapy[S]
by: Arnab Chattopadhyay, et al.
Published: (2013-04-01)

Transintestinal transport of the anti-inflammatory drug 4F and the modulation of transintestinal cholesterol efflux[S]
by: David Meriwether, et al.
Published: (2016-07-01)

The role of dysfunctional HDL in atherosclerosis
by: Mohamad Navab, et al.
Published: (2009-01-01)

D-4F reduces EO6 immunoreactivity, SREBP-1c mRNA levels, and renal inflammation in LDL receptor-null mice fed a Western diet
by: Georgette M. Buga, et al.
Published: (2008-01-01)

Role of enterocyte stearoyl-Co-A desaturase-1 in LDLR-null mice
by: Pallavi Mukherjee, et al.
Published: (2018-10-01)

D-4F decreases brain arteriole inflammation and improves cognitive performance in LDL receptor-null mice on a Western diet
by: Georgette M. Buga, et al.
Published: (2006-10-01)

Thematic review series: The Pathogenesis of Atherosclerosis The oxidation hypothesis of atherogenesis: the role of oxidized phospholipids and HDL
by: Mohamad Navab, et al.
Published: (2004-06-01)

Apolipoprotein Mimetic Peptides: A New Approach for the Treatment of Asthma
by: Xianglan eYao, et al.
Published: (2012-03-01)

Anti-inflammatory and cholesterol-reducing properties of apolipoprotein mimetics: a review
by: C. Roger White, et al.
Published: (2014-10-01)

Subcutaneous Administration of Apolipoprotein J-Derived Mimetic Peptide d-[113–122]apoJ Improves LDL and HDL Function and Prevents Atherosclerosis in LDLR-KO Mice
by: Andrea Rivas-Urbina, et al.
Published: (2020-05-01)

The Role of HDL and HDL Mimetic Peptides as Potential Therapeutics for Alzheimer’s Disease
by: Dustin Chernick, et al.
Published: (2020-09-01)

High-density Lipoproteins and Apolipoprotein A-I: Potential New Players in the Prevention and Treatment of Lung Disease
by: Elizabeth M. Gordon, et al.
Published: (2016-09-01)

L-4F treatment reduces adiposity, increases adiponectin levels, and improves insulin sensitivity in obese mice*
by: Stephen J. Peterson, et al.
Published: (2008-08-01)

Artificial High Density Lipoprotein Nanoparticles in Cardiovascular Research
by: Karin Kornmueller, et al.
Published: (2019-08-01)

Apolipoprotein and LRP1-Based Peptides as New Therapeutic Tools in Atherosclerosis
by: Aleyda Benitez Amaro, et al.
Published: (2021-08-01)

Long-Term Liver Expression of an Apolipoprotein A-I Mimetic Peptide Attenuates Interferon-Alpha-Induced Inflammation and Promotes Antiviral Activity
by: Myriam Fernandez-Sendin, et al.
Published: (2021-02-01)

Anti-tumorigenic and Platinum-Sensitizing Effects of Apolipoprotein A1 and Apolipoprotein A1 Mimetic Peptides in Ovarian Cancer
by: Aline T. Marinho, et al.
Published: (2019-01-01)

Influence of route of administration and lipidation of apolipoprotein A-I peptide on pharmacokinetics and cholesterol mobilization
by: Jie Tang, et al.
Published: (2017-01-01)

Apolipoprotein E and its mimetic peptide suppress Th1 and Th17 responses in experimental autoimmune encephalomyelitis
by: Junjie Wei, et al.
Published: (2013-08-01)

Collagen Mimetic Peptides
by: Yujia Xu, et al.
Published: (2021-01-01)

Peptide transport in Candida albicans and synthetic antifungal agents
by: Shallow, David A.
Published: (1986)

D-4F Ameliorates Contrast Media–Induced Oxidative Injuries in Endothelial Cells via the AMPK/PKC Pathway
by: Yansong Guo, et al.
Published: (2021-02-01)

Efficacy and Safety of High-Density Lipoprotein/Apolipoprotein A1 Replacement Therapy in Humans and Mice With Atherosclerosis: A Systematic Review and Meta-Analysis
by: Ayiguli Abudukeremu, et al.
Published: (2021-08-01)

Blockade of Glial Connexin 43 Hemichannels Reduces Food Intake
by: Florent Guillebaud, et al.
Published: (2020-10-01)

Antifungal Potential of Host Defense Peptide Mimetics in a Mouse Model of Disseminated Candidiasis
by: Mobaswar Hossain Chowdhury, et al.
Published: (2018-02-01)

Regulation of autotaxin expression and secretion by lysophosphatidate and sphingosine 1-phosphate
by: Matthew G.K. Benesch, et al.
Published: (2015-06-01)

Cerebellar Cells Self-Assemble into Functional Organoids on Synthetic, Chemically Crosslinked ECM-Mimicking Peptide Hydrogels
by: Zbigniev Balion, et al.
Published: (2020-05-01)

Cholesterol Binding Activity of ApoAI Mimetic Peptide L4F
by: Onkar, Sayali S.
Published: (2013)

Novel fatty acyl apoE mimetic peptides have increased potency to reduce plasma cholesterol in mice and macaques[S]
by: G.M. Anantharamaiah, et al.
Published: (2018-11-01)

Increased formation of lysophosphatidic acids by lysophospholipase D in serum of hypercholesterolemic rabbits
by: Akira Tokumura, et al.
Published: (2002-02-01)

Oral apolipoprotein A-I mimetic peptide improves cognitive function and reduces amyloid burden in a mouse model of Alzheimer's disease
by: Shaila P. Handattu, et al.
Published: (2009-06-01)

In silico and in vitro Evaluation of Mimetic Peptides as Potential Antigen Candidates for Prophylaxis of Leishmaniosis
by: Deborah Carbonera Guedes, et al.
Published: (2021-01-01)

Cannot write session to /tmp/vufind_sessions/sess_uqehuntsu8f2tc87u3stcr9v4o